willow semaglutide Say Hello to – A Personalized Approach to Medication Assisted Weight Loss FDA-Approved Oral Semaglutide: The First

doi: 10.1523/JNEUROSCI.3588-08.2008 142 MohammadiM.NasehiM.ZarrindastM

10.1111/j.1365-2982.2008.01113.x 69

A significant contributing factor to the prevalence of T2DM is obesity, which is strongly associated with serious consequences such as chronic kidney disease, hypertension, stroke, and liver disease that impair both the quality and quantity of life as life expectancy declines with rising body mass index (BMI) [2]

References Campbell T, Cullen B (2023) Estimating the effect of physical activity on cognitive function within the UK Biobank cohort

Doctor visits, prescription medications for related conditions, and eventual hospitalizations cost far more than preventive weight management